Literature DB >> 11727270

Mutation of von Hippel-Lindau tumor suppressor gene in a sporadic endolymphatic sac tumor.

S Hamazaki1, M Yoshida, M Yao, Y Nagashima, K Taguchi, H Nakashima, S Okada.   

Abstract

Endolymphatic sac tumor (ELST) is a low-grade adenocarcinoma of the temporal bone that is presumed to originate from the endolymphatic system. Although ELSTs are extremely rare in the general population, a significant number of studies have documented the occurrence of ELST among patients with von Hippel-Lindau (VHL) disease. Because of the rarity of the tumor, however, few cases of ELST have been analyzed for mutations of the VHL tumor suppressor gene. In this study, we reported a Japanese male patient with sporadic ELST, along with a molecular genetic analysis of the VHL gene. The light microscopic and immunohistochemical features and clinical presentations were typical of ELST. Sequencing studies of the tumor DNA disclosed a G to T substitution of nucleotide 564, which resulted in an amino acid substitution (Trp to Cys). This is the first report of the VHL gene mutation in a sporadic Japanese case of ELST. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11727270     DOI: 10.1053/hupa.2001.28961

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  8 in total

1.  Origin of endolymphatic sac tumor.

Authors:  Leslie Michaels
Journal:  Head Neck Pathol       Date:  2007-11-27

Review 2.  A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.

Authors:  Sarah Scollon; Amanda Knoth Anglin; Martha Thomas; Joyce T Turner; Kami Wolfe Schneider
Journal:  J Genet Couns       Date:  2017-03-29       Impact factor: 2.537

3.  Endolymphatic sac tumor: case report and literature review.

Authors:  Hongliang Ge; Hongyao Wang; Jiawei Cai; Xinting Zhang; Wenzhong Mei; Xiyue Wu; Dezhi Kang
Journal:  Chin Neurosurg J       Date:  2020-05-09

4.  Endolymphatic sac tumor with von Hippel-Lindau disease: report of a case with atypical pathology of endolymphatic sac tumor.

Authors:  Xiang Yang; Xue-Song Liu; Yuan Fang; Xiu-Hui Zhang; Yue-Kang Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

Review 5.  Endolymphatic sac tumor: case report and review of the literature.

Authors:  Yan-Hua Sun; Wen Wen; Jun-Hui Wu; Jian-Ming Song; Hong Guan; Kai-Xin Wang; Mei-Quan Xu
Journal:  Diagn Pathol       Date:  2012-04-02       Impact factor: 2.644

6.  Epidermal growth factor receptor as a novel molecular target for aggressive papillary tumors in the middle ear and temporal bone.

Authors:  Shigeru Kawabata; M Christine Hollander; Jeeva P Munasinghe; Lauren R Brinster; José R Mercado-Matos; Jie Li; Lucia Regales; William Pao; Pasi A Jänne; Kwok-Kin Wong; John A Butman; Russell R Lonser; Marlan R Hansen; Richard K Gurgel; Alexander O Vortmeyer; Phillip A Dennis
Journal:  Oncotarget       Date:  2015-05-10

7.  Endolymphatic sac tumour in von Hippel-Lindau disease: management strategies.

Authors:  E Zanoletti; L Girasoli; D Borsetto; G Opocher; A Mazzoni; A Martini
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-10       Impact factor: 2.124

8.  Clinical response to pazopanib in a patient with endolymphatic sac tumor not associated with von Hippel-Lindau syndrome.

Authors:  Thomas Nelson; Jethro Hu; Serguei Bannykh; Xuemo Fan; Jeremy Rudnick; Eric Vail
Journal:  CNS Oncol       Date:  2020-03-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.